J. Goldman & CO LP Adamas Pharmaceuticals, Inc. Transaction History

J. Goldman & CO LP

  • $3.8 Billion
  • Q1 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
N/A
-97,480 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
N/A
97,480 New
97,480 $422,000

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email